Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma

doi:10.4254/wjh.v14.i5.885

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4587)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

281

WORD

HTML

2532

Figures (1-1)

430

Tables (1-2)

416

Sum=3738

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

317

Download

532

Sum=849

May 27, 2022 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. May 27, 2022; 14(5): 885-895
Published online May 27, 2022. doi: 10.4254/wjh.v14.i5.885

Open in New Tab Full Size Figure Download Figure

Figure 1 Barcelona clinic liver criteria guidelines for hepatocellular carcinoma treatment.

Citation: Zane KE, Nagib PB, Jalil S, Mumtaz K, Makary MS. Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma. World J Hepatol 2022; 14(5): 885-895
URL: https://www.wjgnet.com/1948-5182/full/v14/i5/885.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i5.885